Economic Overview - In January-February 2026, the industrial added value increased by 6.3% year-on-year, slightly above the historical average of 6.0% since 2015[6] - The total retail sales of consumer goods reached 86,079 billion yuan, with a year-on-year growth of 2.8%[6] - Fixed asset investment (excluding rural households) was 52,721 billion yuan, showing a year-on-year increase of 1.8%[6] Investment Insights - Investment unexpectedly turned positive, rebounding from negative growth in the previous year, marking a significant highlight in the early economic data[6] - High-tech manufacturing showed remarkable performance, significantly outpacing overall industrial growth, indicating early success in cultivating new productive forces[3] Infrastructure and Fiscal Policy - Infrastructure investment saw a recovery, with public utilities, transportation, and water conservancy sectors all turning from negative to positive growth[3] - Fiscal spending accelerated, with a reduction of 350 billion yuan in February's fiscal deposits, indicating faster disbursement of funds[3] Manufacturing Sector - Manufacturing investment recorded a year-on-year growth of 3.1% in January-February, marking a strong rebound from the negative growth experienced since April 2025[4] - The leading sectors in manufacturing investment were primarily in mid-to-lower stream industries, such as transportation equipment and electrical machinery[4] Consumer Trends - The Spring Festival effect boosted retail sales, with restaurant and service retail sales growing by 4.8% and 5.6% year-on-year, respectively[4] - Consumption related to "trade-in" policies improved, although there was significant internal structural differentiation, particularly in the automotive sector, which continued to experience negative growth[5][7]

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1][7]. Core Viewpoints - The price of methionine and vitamin E has increased significantly, with methionine prices rising by 84.66% and vitamin E by 40.54% since the beginning of the year [2]. - The global methionine production capacity is approximately 2.7 million tons per year, with 44% of this capacity facing challenges outside of China and the US, particularly in Europe and Asia [2][3]. - The rising costs of raw materials and energy, including a 29% increase in Brent crude oil prices and a 56% increase in Dutch TTF natural gas prices, are expected to continue affecting production costs [3][8]. - The methionine and vitamin E industries are characterized by oligopolistic market structures, allowing major companies to exert pricing power [3][9]. - New Hope Liuhe, as the third-largest methionine producer and the largest vitamin E producer globally, is well-positioned to benefit from the price increases in these products [4][19]. Summary by Relevant Sections Methionine Market - The demand for methionine is expected to grow at a compound annual growth rate (CAGR) of 5.21% from 2014 to 2024, increasing from 1.023 million tons to 1.7 million tons [5]. - The production capacity distribution shows that China accounts for approximately 40% of global methionine capacity, while Europe and Asia (excluding China) account for over 40% combined [6]. Vitamin E Market - The global vitamin E market is highly concentrated, with only six major producers controlling 92% of the market [16]. - The price of vitamin E has also seen a significant increase, with a 40.54% rise since the beginning of the year [18]. Financial Projections - The company is expected to achieve net profits of 6.792 billion yuan in 2025, 7.248 billion yuan in 2026, and 7.737 billion yuan in 2027, with corresponding price-to-earnings ratios of 17.8, 16.7, and 15.6 [19][23].

Group 1: Company Overview and Products - The company's main lithium-ion battery electrolyte additives include lithium salt additives such as LiDFP, LiTFSI, LiDFOB, and LiTFS, which are widely used in power lithium-ion batteries to enhance performance [2] - The company does not produce lithium hexafluorophosphate (LiPF6) but has a 25% stake in Jiangsu Tairui Lanteng Material Technology Co., which is set to produce 30,000 tons of LiPF6 annually [2][3] - The first phase of the LiPF6 project, with a capacity of 15,000 tons, began trial production in August 2024, while the second phase is in progress [2][3] Group 2: Financial Performance and Investments - In December 2025, the company reduced its stake in Tianji Co., selling 9,973,803 shares for a pre-tax investment gain of approximately 390 million yuan, resulting in a net gain of about 290 million yuan after taxes [3] - As of January 30, 2026, the company still holds 19,744,515 shares of Tianji Co., representing a 3.94% ownership [3] Group 3: Production Capacity and Market Impact - The company's electronic chemical production capacity was 279,990.42 tons in the first half of 2025, calculated based on production time [3] - The significant price increase of LiPF6 in Q4 2025 will impact the company's raw material costs, but the effects are manageable due to strategic investments [3] Group 4: Optical Materials and Solid-State Battery Development - The company is a leader in the optical materials sector, benefiting from the shift of LCD production to China and the growing demand for consumer electronics [3] - The company is actively developing solid-state battery materials, with LiTFSI already in mass production and collaborations with various solid-state battery enterprises [3]

Group 1: Report Date and Focus - The report is dated March 12, 2026, and focuses on lithium carbonate inventory data [1] Group 2: Analysts' Information - The analysts are Shao Wanyi (Investment Consulting Qualification No.: Z0015722, email: shaowanyi@gtht.com) and Zhang Hang (Investment Consulting Qualification No.: Z0018008, email: zhanghang2@gtht.com) [2] Group 3: Fundamental Data of Lithium Carbonate - The closing price of the 2605 contract is 155,040, with a change of -7,960 compared to T-1 [3] - The trading volume of the 2605 contract is 267,346, with a change of 41,073 compared to T-1 [3] - The open interest of the 2605 contract is 330,436, with a change of -2,081 compared to T-1 [3] - Similar data is provided for the 2607 contract, including closing price, trading volume, and open interest [3] - Other data such as warehouse receipts, basis, raw material prices, and lithium salt prices are also presented [3] Group 4: Macro and Industry News - Tianci Materials announced that in 2025, its operating income was 16.649 billion yuan, a year-on-year increase of 33.00%, and its net profit was 1.362 billion yuan, a year-on-year increase of 181.43%. The company plans to distribute a cash dividend of 3 yuan per 10 shares (tax included) [4] - The "Spring Warm Purchase" car consumption reward event in Chengdu's Wenjiang District will start on March 11, with a total fund scale of 2 million yuan. Individual consumers can get a maximum reward of 8,000 yuan for buying a new car [5] Group 5: Trend Intensity - The trend intensity of lithium carbonate is 0, indicating a neutral outlook [5]

Financial Performance - In 2025, the company achieved a revenue of CNY 16.65 billion, representing a year-on-year growth of 33% [1] - The net profit attributable to shareholders was CNY 1.362 billion, with a significant increase of 181.43% [1] - The net profit after deducting non-recurring gains and losses was CNY 1.36 billion, up by 256.32% [1] - Basic earnings per share reached CNY 0.71 [1] Product Sales and Market Trends - The sales volume of the core product, electrolyte, exceeded 720,000 tons, marking a year-on-year growth of approximately 44% [1] - The annual sales of daily chemical materials surpassed 120,000 tons, reflecting a 10% increase compared to the previous year [1] - The overall revenue from the daily chemical materials business grew by 10.69% [1] Production Capacity and Resource Management - The company plans to add 35,000 tons of new production capacity for lithium hexafluorophosphate, with production expected to commence in the second half of 2026 [2] - The company is actively diversifying its lithium resource layout, including mining and recycling operations, to optimize raw material costs [2] - The production capacity for iron phosphate is currently at 300,000 tons, with efforts to improve operational efficiency and reduce costs [2] New Material Development - The current addition ratio of LiFSI in electrolytes is approximately 2%-2.5%, with expectations for an increase due to rising demand for high-performance formulations [3] - The company is in the kilogram-level trial production phase for sulfide solid electrolytes, with a pilot production line expected to be operational in Q3 2026 [3] - The company has established production capabilities for sodium-ion electrolytes and will gradually increase production based on market demand [3] International Expansion and IPO Progress - Overseas projects in Morocco and the USA have commenced, with completion expected between late 2027 and mid-2028 [4] - The company submitted its Hong Kong IPO application in September 2025 and is currently awaiting approval from the China Securities Regulatory Commission, with a typical review period of 6-9 months [5]

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 52.63, which is an increase of 38% from the previous target price of RMB 38.24 [1][4]. Core Insights - The report highlights that the geopolitical conflicts in the Middle East have led to increased prices and supply shortages of key raw materials such as LNG, methanol, propane/propylene, and sulfur, which are essential for the production of methionine. This instability in raw material supply is expected to drive up methionine prices, benefiting the company due to its relatively stable domestic raw material and energy supply [1][2]. - The company is projected to gain market share globally as its production capacity for methionine and vitamins is more competitive compared to overseas firms, especially in the context of declining overseas supply stability [1][3]. - The report anticipates a continued upward trend in methionine prices, with a forecasted net profit of RMB 67 billion, RMB 85 billion, and RMB 96 billion for the years 2025 to 2027, respectively, reflecting a compound annual growth rate (CAGR) of 18% [4]. Summary by Sections Supply and Demand Dynamics - Since the end of February, geopolitical tensions have caused price increases and supply shortages for raw materials like natural gas and sulfur, impacting overseas methionine production. Companies such as Winco and Sumitomo Chemical have declared force majeure due to these supply issues [2]. - The domestic methionine market price as of March 10 was RMB 28.75 per kg, a 63% increase since the beginning of the year, indicating a significant widening of the price gap compared to international markets [2]. Vitamin Market Outlook - The vitamin market, particularly for Vitamin E, has also shown signs of improvement, with prices rising to RMB 68.5 per kg, a 23% increase since the start of the year. The report suggests that supply constraints from overseas will further enhance the company's market position [3]. Financial Projections - The company’s projected revenues for 2024, 2025, 2026, and 2027 are RMB 21.61 billion, RMB 23.88 billion, RMB 27.88 billion, and RMB 31.05 billion, respectively, with corresponding net profits of RMB 5.87 billion, RMB 6.73 billion, RMB 8.51 billion, and RMB 9.63 billion [10][33]. - The report estimates an increase in the company's net profit forecasts for 2026 and 2027 by 16% and 19%, respectively, due to the anticipated rise in methionine prices [4].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 52.63, which is an increase of 38% from the previous target price of RMB 38.24 [1][4]. Core Views - The report highlights that the geopolitical conflicts in the Middle East have led to supply disruptions and price increases for key raw materials such as LNG, methanol, propane/propylene, and sulfur, which are essential for the production of methionine. This situation is expected to drive methionine prices upward, benefiting the company due to its stable domestic raw material and energy supply [1][2]. - The company is projected to gain market share globally as its production capacity for methionine and vitamins is more competitive compared to overseas firms, especially in light of the declining stability of overseas supply [1][3]. - The report anticipates a continued upward trend in methionine prices driven by increasing downstream demand and declining overseas supply, which positions the company favorably [2][3]. Summary by Sections Investment Rating - The company maintains a "Buy" rating with a target price of RMB 52.63, reflecting a 38% increase from the previous target [1][4]. Market Conditions - Geopolitical tensions have caused supply shortages and price hikes in essential raw materials, which are expected to benefit the company's methionine production [1][2]. - The global methionine production capacity is projected to be around 2.55 million tons by 2025, with domestic production accounting for approximately 40% [2]. Financial Projections - The company's net profit forecasts for 2025-2027 are adjusted to RMB 67 billion, RMB 85 billion, and RMB 96 billion respectively, with a compound annual growth rate (CAGR) of 18% [4]. - The report estimates that the company's earnings per share (EPS) will increase from RMB 1.91 in 2024 to RMB 3.13 in 2027 [10][33].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a revenue of 16.65 billion yuan for 2025, representing a year-on-year increase of 33%. The net profit attributable to shareholders was 1.36 billion yuan, up 181.4% year-on-year, with a gross margin of 22.2% [9] - The company expects to ship over 1 million tons of electrolyte in 2026, with a significant increase in profitability due to rising prices of hexafluorophosphate [9] - The company has effectively controlled expenses, with a notable increase in operating cash flow in Q4 2025 [9] Financial Performance Summary - Total revenue for 2025 is projected at 16.65 billion yuan, with a year-on-year growth of 33% [10] - The net profit attributable to shareholders is expected to reach 1.36 billion yuan, reflecting a year-on-year increase of 181.43% [10] - The earnings per share (EPS) for 2025 is estimated at 0.67 yuan, with a price-to-earnings (P/E) ratio of 64.75 [10] - The company anticipates a net profit of 7.03 billion yuan in 2026, corresponding to a P/E ratio of 20x [9][10]

Group 1: Inflation Data Overview - February CPI increased from 0.2% to 1.3%, exceeding expectations of 0.9%, marking the highest level in three years[2] - Core CPI rose from 0.8% to 1.8%, with an average of 1.3% for January-February, the highest since 2020[2] - PPI narrowed its year-on-year decline from -1.4% to -0.9%, with expectations of -1.2%[2] Group 2: CPI and PPI Drivers - Core CPI's unexpected rise was primarily driven by competitive service prices, contributing approximately 0.26 percentage points to the 0.3 percentage point seasonal increase[3] - PPI's 0.4% month-on-month increase was significantly above the expected 0.1%, driven by input factors from oil and non-ferrous metals, contributing about 0.11 and 0.36 percentage points respectively[5][15] - The ongoing improvement in midstream manufacturing supply and demand has led to a sustained price increase, with PPI in this sector rising approximately 0.4%[6] Group 3: Price Trends and Market Implications - CPI's month-on-month increase of 1% was supported by significant price hikes in travel and entertainment services, as well as durable goods like automobiles and gold[2] - The average month-on-month core CPI for January-February was 0.5%, significantly higher than the past five-year average of 0.2%[3] - The potential for a positive shift in overall price levels is indicated, with government reports suggesting a move from negative to positive price growth this year[6][16] Group 4: Risks and Observations - The ongoing geopolitical uncertainties in the Middle East pose risks to inflation trends[6] - The observed price increases in competitive service sectors may indicate a recovery potential, as these prices have been relatively low since 2022[4][11]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's 2025 annual report shows performance in line with market expectations, with significant price elasticity for hexafluorophosphate [9] - The company achieved a revenue of 16.65 billion yuan in 2025, representing a year-on-year increase of 33%, and a net profit attributable to shareholders of 1.36 billion yuan, up 181.4% year-on-year [9] - The report highlights a strong growth forecast for 2026, with expected shipments of electrolyte exceeding 1 million tons, a 40% increase year-on-year [9] Financial Summary - Total revenue for 2025 is projected at 16.65 billion yuan, with a year-on-year growth of 33% [9] - Net profit attributable to shareholders for 2025 is expected to be 1.36 billion yuan, reflecting a year-on-year increase of 181.4% [9] - The earnings per share (EPS) for 2025 is estimated at 0.67 yuan, with a price-to-earnings (P/E) ratio of 64.75 [1][10] - The company anticipates a net profit of 7.03 billion yuan in 2026, with a corresponding P/E ratio of 12.54 [10] - The gross profit margin for 2025 is reported at 22.2%, an increase of 3.4 percentage points year-on-year [9]